NOVN
$2.16
Novan
($.04)
(1.82%)
NOVN
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  ($0.41)
Revenue:  $1.10 Mil
Tuesday
Feb 11
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when NOVN reports earnings?
Beat
Meet
Miss

Where is NOVN's stock price going from here?
Up
Flat
Down
Stock chart of NOVN
Analysts
Summary of analysts' recommendations for NOVN
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Noven Pharmaceuticals is a leader in the development and manufacture of advanced transdermal and transmucosal drug delivery products and technologies. Noven's principal commercialized products are transdermal drug delivery systems for use in hormone replacement therapy. Noven has an active research and development program with numerous products in development. Research efforts are focused primarily on four therapeutic categories: hormone replacement therapy, central nervous system conditions, cardiovascular disease and pain management.